Literature DB >> 12684613

Cloacogenic adenocarcinoma of the vulva presenting as recurrent Bartholin's gland infection.

So-Haei Liu1, Chih-Ming Ho, Shih-Hung Huang, Bor-Yuan Shih, Fa-Kung Lee.   

Abstract

Primary adenocarcinoma of the vulva of the cloacogenic type is extremely rare. We report the case of a 49-year-old patient with a 6-year history of recurrent left Bartholin's gland infection and a 1-year history of an ulcerated tumor on the similar lower aspect of the left labium majus. Fine needle biopsy revealed adenocarcinoma and wide local excision with bilateral superficial inguinal lymph node dissection was performed. The patient was well and disease-free at 24 months after the operation. This case provides a good example of why an early biopsy should be performed for any persistent anogenital lesion. Although the reported data on cloacogenic adenocarcinoma are limited, a wide local excision appears to be the most widely used treatment strategy for any vulvar cancer of 2 cm or less in diameter.

Entities:  

Mesh:

Year:  2003        PMID: 12684613

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  3 in total

1.  Primary Villoglandular Mucinous Adenocarcinoma of the Vulva.

Authors:  Akiko Matsuzaki; Masanao Saio; Noritake Kosuge; Hajime Aoyama; Tomoko Tamaki; Hirofumi Matsumoto; Naoki Yoshimi
Journal:  Case Rep Pathol       Date:  2017-04-19

2.  Intestinal-type adenocarcinoma of the Bartholin gland: A case report and literature review.

Authors:  Javier Martín-Vallejo; Patricia Molina-Bellido; Juan B Laforga; Pedro A Clemente-Pérez
Journal:  Gynecol Oncol Rep       Date:  2021-07-23

3.  An unexpected complete remission of advanced intestinal-type vulvar adenocarcinoma after neoadjuvant chemotherapy: a case report and a literature review.

Authors:  Angela Musella; Claudia Marchetti; Laura Salerno; Laura Vertechy; Roberta Iadarola; Irene Pecorella; Pierluigi Benedetti Panici
Journal:  Case Rep Obstet Gynecol       Date:  2013-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.